Based on age, the International Staging System (INSS), histology, DNA copy number, MYCN amplification and other characteristics, NB patients are classified into very low-, low-, intermediate- and high-risk groups according to Children's Oncology Groups (COGs) 2, 3. The gene discussed is MYCN; the disease is neuroblastoma.